Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 8.59657196 |
2 | hemidesmosome assembly (GO:0031581) | 6.43944615 |
3 | establishment of skin barrier (GO:0061436) | 6.27188735 |
4 | regulation of water loss via skin (GO:0033561) | 6.06022126 |
5 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 5.39043237 |
6 | response to peptidoglycan (GO:0032494) | 4.96524319 |
7 | keratinization (GO:0031424) | 4.85279691 |
8 | lymph vessel development (GO:0001945) | 4.81648733 |
9 | keratinocyte proliferation (GO:0043616) | 4.63188305 |
10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.55331177 |
11 | neutrophil activation involved in immune response (GO:0002283) | 4.34365710 |
12 | multicellular organismal water homeostasis (GO:0050891) | 4.26118944 |
13 | keratinocyte differentiation (GO:0030216) | 4.22792728 |
14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21188955 |
15 | interferon-gamma secretion (GO:0072643) | 4.20190811 |
16 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.16052128 |
17 | regulation of chemokine secretion (GO:0090196) | 4.09051378 |
18 | negative regulation of cell fate specification (GO:0009996) | 4.04319815 |
19 | epithelial cell-cell adhesion (GO:0090136) | 4.03158434 |
20 | atrioventricular valve morphogenesis (GO:0003181) | 4.00280806 |
21 | response to muramyl dipeptide (GO:0032495) | 3.82385472 |
22 | negative regulation of cell fate commitment (GO:0010454) | 3.78367306 |
23 | cellular extravasation (GO:0045123) | 3.70101586 |
24 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.60236166 |
25 | sphingoid metabolic process (GO:0046519) | 3.43749649 |
26 | surfactant homeostasis (GO:0043129) | 3.42142832 |
27 | water homeostasis (GO:0030104) | 3.42137483 |
28 | * epidermal cell differentiation (GO:0009913) | 3.38434240 |
29 | regulation of cell fate specification (GO:0042659) | 3.35105743 |
30 | modulation by symbiont of host immune response (GO:0052553) | 3.33826931 |
31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33826931 |
32 | modulation by symbiont of host defense response (GO:0052031) | 3.33826931 |
33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33826931 |
34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33826931 |
35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33826931 |
36 | hair cycle (GO:0042633) | 3.33561444 |
37 | molting cycle (GO:0042303) | 3.33561444 |
38 | embryonic process involved in female pregnancy (GO:0060136) | 3.33149540 |
39 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.31453871 |
40 | peptide cross-linking (GO:0018149) | 3.30842921 |
41 | notochord development (GO:0030903) | 3.30396881 |
42 | skin morphogenesis (GO:0043589) | 3.28584550 |
43 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.27911856 |
44 | epidermis development (GO:0008544) | 3.27590760 |
45 | intestinal epithelial cell development (GO:0060576) | 3.17079847 |
46 | negative regulation of stress fiber assembly (GO:0051497) | 3.16247695 |
47 | regulation of cardioblast differentiation (GO:0051890) | 3.16231662 |
48 | macrophage activation involved in immune response (GO:0002281) | 3.14295773 |
49 | transcytosis (GO:0045056) | 3.11863440 |
50 | limb bud formation (GO:0060174) | 3.11338101 |
51 | positive regulation of glomerulus development (GO:0090193) | 3.10982639 |
52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.09129850 |
53 | regulation of mast cell degranulation (GO:0043304) | 3.08799591 |
54 | detection of external biotic stimulus (GO:0098581) | 3.08137491 |
55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07508918 |
56 | regulation of phospholipase A2 activity (GO:0032429) | 3.05726682 |
57 | chemical homeostasis within a tissue (GO:0048875) | 3.03852579 |
58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01717835 |
59 | heart valve morphogenesis (GO:0003179) | 3.01191838 |
60 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.00412655 |
61 | regulation of leukocyte degranulation (GO:0043300) | 3.00011269 |
62 | viral transcription (GO:0019083) | 2.99277524 |
63 | keratinocyte development (GO:0003334) | 2.96523655 |
64 | detection of biotic stimulus (GO:0009595) | 2.96421544 |
65 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.95833559 |
66 | diol metabolic process (GO:0034311) | 2.94647264 |
67 | response to progesterone (GO:0032570) | 2.94125459 |
68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.93837698 |
69 | immunoglobulin mediated immune response (GO:0016064) | 2.91509001 |
70 | ribosomal small subunit biogenesis (GO:0042274) | 2.90496395 |
71 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.90358199 |
72 | mannose metabolic process (GO:0006013) | 2.89952537 |
73 | * response to laminar fluid shear stress (GO:0034616) | 2.87601709 |
74 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.87429216 |
75 | detection of bacterium (GO:0016045) | 2.83595623 |
76 | neutrophil activation (GO:0042119) | 2.82044666 |
77 | endothelium development (GO:0003158) | 2.81799974 |
78 | intermediate filament organization (GO:0045109) | 2.79811143 |
79 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79654542 |
80 | negative regulation of interleukin-12 production (GO:0032695) | 2.79343657 |
81 | phospholipid scrambling (GO:0017121) | 2.79279238 |
82 | renal system process involved in regulation of blood volume (GO:0001977) | 2.78410179 |
83 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77411564 |
84 | detection of other organism (GO:0098543) | 2.77214818 |
85 | regulation of interleukin-8 secretion (GO:2000482) | 2.75956552 |
86 | macrophage activation (GO:0042116) | 2.73944822 |
87 | translational termination (GO:0006415) | 2.73318127 |
88 | cardiac right ventricle morphogenesis (GO:0003215) | 2.72418770 |
89 | ectoderm development (GO:0007398) | 2.71844983 |
90 | cyclooxygenase pathway (GO:0019371) | 2.71342533 |
91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70835660 |
92 | sphingosine metabolic process (GO:0006670) | 2.70805365 |
93 | granulocyte activation (GO:0036230) | 2.70733892 |
94 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.70683599 |
95 | positive regulation of type 2 immune response (GO:0002830) | 2.69274200 |
96 | negative regulation of interleukin-6 production (GO:0032715) | 2.68768700 |
97 | gland morphogenesis (GO:0022612) | 2.68022860 |
98 | glomerular visceral epithelial cell development (GO:0072015) | 2.67038955 |
99 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64565718 |
100 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.63431471 |
101 | regulation of glomerular filtration (GO:0003093) | 2.63363227 |
102 | neural crest cell development (GO:0014032) | 2.63116681 |
103 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62157088 |
104 | establishment of endothelial barrier (GO:0061028) | 2.62008454 |
105 | mRNA transcription (GO:0009299) | 2.61655133 |
106 | * negative regulation of interleukin-8 production (GO:0032717) | 2.61431796 |
107 | regulation of glomerulus development (GO:0090192) | 2.61151667 |
108 | cell wall macromolecule catabolic process (GO:0016998) | 2.58335980 |
109 | regulation of cell fate commitment (GO:0010453) | 2.58242943 |
110 | regulation of mast cell activation (GO:0033003) | 2.57692312 |
111 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57692009 |
112 | detection of molecule of bacterial origin (GO:0032490) | 2.56920676 |
113 | pinocytosis (GO:0006907) | 2.55601371 |
114 | positive regulation of mast cell activation (GO:0033005) | 2.54233082 |
115 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.52958852 |
116 | glomerular basement membrane development (GO:0032836) | 2.49147409 |
117 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.49120158 |
118 | regulation of gene silencing by miRNA (GO:0060964) | 2.49120158 |
119 | regulation of gene silencing by RNA (GO:0060966) | 2.49120158 |
120 | positive regulation of leukocyte degranulation (GO:0043302) | 2.47971129 |
121 | neutrophil mediated immunity (GO:0002446) | 2.47562248 |
122 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47416383 |
123 | microglial cell activation (GO:0001774) | 2.46545725 |
124 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.46302998 |
125 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.45835934 |
126 | positive regulation of odontogenesis (GO:0042482) | 2.45619742 |
127 | mitotic cell cycle arrest (GO:0071850) | 2.45531838 |
128 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.45054128 |
129 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.44619334 |
130 | positive regulation of mast cell degranulation (GO:0043306) | 2.44619334 |
131 | regulation of ruffle assembly (GO:1900027) | 2.43597368 |
132 | virion attachment to host cell (GO:0019062) | 2.42942371 |
133 | adhesion of symbiont to host cell (GO:0044650) | 2.42942371 |
134 | negative regulation of fatty acid transport (GO:2000192) | 2.42328919 |
135 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.42326214 |
136 | regulation of interleukin-6 production (GO:0032675) | 2.41959127 |
137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39843364 |
138 | germinal center formation (GO:0002467) | 2.39450823 |
139 | cell-substrate junction assembly (GO:0007044) | 2.38908868 |
140 | radial glial cell differentiation (GO:0060019) | 2.37251117 |
141 | regulation of type 2 immune response (GO:0002828) | 2.36801326 |
142 | regulation of regulated secretory pathway (GO:1903305) | 2.36031617 |
143 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.35960515 |
144 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.35708269 |
145 | regulation of p38MAPK cascade (GO:1900744) | 2.35330674 |
146 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.35109524 |
147 | lateral sprouting from an epithelium (GO:0060601) | 2.34950116 |
148 | peptide catabolic process (GO:0043171) | 2.34865333 |
149 | face development (GO:0060324) | 2.34509083 |
150 | endocardial cushion morphogenesis (GO:0003203) | 2.34265963 |
151 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.33747682 |
152 | endothelial cell morphogenesis (GO:0001886) | 2.33722999 |
153 | regulation of antigen processing and presentation (GO:0002577) | 2.33187186 |
154 | adhesion of symbiont to host (GO:0044406) | 2.32209149 |
155 | regulation of vitamin metabolic process (GO:0030656) | 2.32187199 |
156 | regulation of cardioblast proliferation (GO:0003264) | 2.31801814 |
157 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.31801814 |
158 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.31634845 |
159 | eyelid development in camera-type eye (GO:0061029) | 2.31473287 |
160 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.31463771 |
161 | T-helper cell differentiation (GO:0042093) | 2.31463771 |
162 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.31215935 |
163 | positive regulation of chemokine secretion (GO:0090197) | 2.31036796 |
164 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.30629600 |
165 | lipoxygenase pathway (GO:0019372) | 2.29955755 |
166 | glomerular epithelial cell development (GO:0072310) | 2.29091784 |
167 | myeloid cell activation involved in immune response (GO:0002275) | 2.28970064 |
168 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.26122831 |
169 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.25556028 |
170 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.24919464 |
171 | wound healing, spreading of epidermal cells (GO:0035313) | 2.23918792 |
172 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.23074347 |
173 | production of molecular mediator of immune response (GO:0002440) | 2.22145745 |
174 | regulation of tolerance induction (GO:0002643) | 2.21451249 |
175 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.21212016 |
176 | positive regulation of antigen processing and presentation (GO:0002579) | 2.19833941 |
177 | positive regulation of interleukin-6 production (GO:0032755) | 2.19577023 |
178 | negative regulation of T cell mediated immunity (GO:0002710) | 2.19229101 |
179 | response to fungus (GO:0009620) | 2.18827695 |
180 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.18790716 |
181 | regulation of tumor necrosis factor production (GO:0032680) | 2.16265994 |
182 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.16087665 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.61872545 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.74402797 |
3 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.16568540 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.16337893 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07547795 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.81258327 |
7 | * KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.65963463 |
8 | * KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.65963463 |
9 | * KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.65963463 |
10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.56656858 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40567754 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33366574 |
13 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.31620408 |
14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22114538 |
15 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.19856393 |
16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.12159329 |
17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09737101 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07711608 |
19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.05134236 |
20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 11.3058672 |
21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98830007 |
22 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.94924537 |
23 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.94924537 |
24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92196898 |
25 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.91726929 |
26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91609933 |
27 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.89535841 |
28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88527094 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84892970 |
30 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84290796 |
31 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.83933860 |
32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80986468 |
33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.79770030 |
34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77539592 |
35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.76721837 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76558530 |
37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76274053 |
38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72810194 |
39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.66537491 |
40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61820963 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61557981 |
42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60256434 |
43 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60043051 |
44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.58152109 |
45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57316719 |
46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56881788 |
47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56313143 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55528196 |
49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55458098 |
50 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52819294 |
51 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52117631 |
52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48141493 |
53 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46420789 |
54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45994620 |
55 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.45253301 |
56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.41217131 |
57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38503901 |
58 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.38301857 |
59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38187665 |
60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36177600 |
61 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.36123059 |
62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35359557 |
63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35089038 |
64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34161094 |
65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32534674 |
66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.32111173 |
67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31390348 |
68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29773210 |
69 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28479786 |
70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27795911 |
71 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26950442 |
72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26477230 |
73 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25869179 |
74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25845669 |
75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24484684 |
76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24100133 |
77 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.21653390 |
78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20593575 |
79 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19590998 |
80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18858324 |
81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18158090 |
82 | MAF_26560356_Chip-Seq_TH1_Human | 1.17168242 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16832543 |
84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15914080 |
85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14492856 |
86 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13830572 |
87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12832390 |
88 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12706596 |
89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11590234 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11545220 |
91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09824224 |
92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08179001 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07483762 |
94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05314457 |
95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04890915 |
96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04389424 |
97 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.04343647 |
98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02987902 |
99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02752999 |
100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02752999 |
101 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02703276 |
102 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02661852 |
103 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02407238 |
104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02263360 |
105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01866490 |
106 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.01689875 |
107 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01630141 |
108 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00816963 |
109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00615687 |
110 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99989384 |
111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98256754 |
112 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98138533 |
113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97839161 |
114 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97298964 |
115 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96505346 |
116 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.96461640 |
117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96387408 |
118 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95931105 |
119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94376200 |
120 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94110363 |
121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93892592 |
122 | MYB_26560356_Chip-Seq_TH2_Human | 0.93536612 |
123 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93441445 |
124 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93163133 |
125 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93106622 |
126 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.92515679 |
127 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92319592 |
128 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91305201 |
129 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.90831587 |
130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90710412 |
131 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89828686 |
132 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.88268891 |
133 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.87589744 |
134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87372208 |
135 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85931954 |
136 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82579269 |
137 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81302211 |
138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79973449 |
139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78942001 |
140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78888042 |
141 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78835698 |
142 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.78486152 |
143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77982484 |
144 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.76632253 |
145 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75208284 |
146 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74419209 |
147 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.73543820 |
148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73233027 |
149 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72647558 |
150 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.72557545 |
151 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72401631 |
152 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72148070 |
153 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.70702391 |
154 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.70682298 |
155 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70177897 |
156 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70177897 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003941_abnormal_skin_development | 5.46928401 |
2 | * MP0002796_impaired_skin_barrier | 4.99938277 |
3 | MP0010234_abnormal_vibrissa_follicle | 4.38933500 |
4 | MP0005275_abnormal_skin_tensile | 4.30974015 |
5 | MP0002254_reproductive_system_inflammat | 3.24536586 |
6 | * MP0005501_abnormal_skin_physiology | 3.21248916 |
7 | MP0004381_abnormal_hair_follicle | 3.05278894 |
8 | * MP0002060_abnormal_skin_morphology | 2.92596095 |
9 | MP0003436_decreased_susceptibility_to | 2.75563934 |
10 | MP0002098_abnormal_vibrissa_morphology | 2.74126550 |
11 | MP0003453_abnormal_keratinocyte_physiol | 2.71374245 |
12 | MP0003303_peritoneal_inflammation | 2.64707015 |
13 | * MP0001216_abnormal_epidermal_layer | 2.64415610 |
14 | MP0010678_abnormal_skin_adnexa | 2.43994943 |
15 | MP0000383_abnormal_hair_follicle | 2.33458890 |
16 | MP0003566_abnormal_cell_adhesion | 2.18873284 |
17 | MP0003136_yellow_coat_color | 2.16233044 |
18 | * MP0010771_integument_phenotype | 2.16076339 |
19 | MP0001835_abnormal_antigen_presentation | 2.03349572 |
20 | MP0005058_abnormal_lysosome_morphology | 2.02895411 |
21 | MP0000579_abnormal_nail_morphology | 2.01580052 |
22 | * MP0000762_abnormal_tongue_morphology | 2.00924321 |
23 | MP0001346_abnormal_lacrimal_gland | 1.98535564 |
24 | MP0004272_abnormal_basement_membrane | 1.97570342 |
25 | MP0002419_abnormal_innate_immunity | 1.97135264 |
26 | MP0004947_skin_inflammation | 1.91193648 |
27 | MP0000377_abnormal_hair_follicle | 1.88091263 |
28 | MP0000647_abnormal_sebaceous_gland | 1.87120511 |
29 | MP0009379_abnormal_foot_pigmentation | 1.84907839 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.80586754 |
31 | MP0006082_CNS_inflammation | 1.79874530 |
32 | MP0003828_pulmonary_edema | 1.73581039 |
33 | MP0005025_abnormal_response_to | 1.72592077 |
34 | * MP0000467_abnormal_esophagus_morphology | 1.71713069 |
35 | MP0005377_hearing/vestibular/ear_phenot | 1.71086409 |
36 | MP0003878_abnormal_ear_physiology | 1.71086409 |
37 | MP0002249_abnormal_larynx_morphology | 1.67463552 |
38 | MP0001958_emphysema | 1.63833074 |
39 | MP0005451_abnormal_body_composition | 1.61552877 |
40 | MP0002148_abnormal_hypersensitivity_rea | 1.61034887 |
41 | MP0003724_increased_susceptibility_to | 1.57622623 |
42 | MP0008260_abnormal_autophagy | 1.57485016 |
43 | MP0005167_abnormal_blood-brain_barrier | 1.54657702 |
44 | MP0002998_abnormal_bone_remodeling | 1.50831921 |
45 | MP0000566_synostosis | 1.50173825 |
46 | MP0005000_abnormal_immune_tolerance | 1.50110909 |
47 | MP0009785_altered_susceptibility_to | 1.49841778 |
48 | MP0009840_abnormal_foam_cell | 1.46361978 |
49 | MP0001853_heart_inflammation | 1.45551774 |
50 | MP0001790_abnormal_immune_system | 1.44469041 |
51 | MP0005387_immune_system_phenotype | 1.44469041 |
52 | MP0008438_abnormal_cutaneous_collagen | 1.44119520 |
53 | MP0010030_abnormal_orbit_morphology | 1.42988976 |
54 | MP0001243_abnormal_dermal_layer | 1.41387923 |
55 | MP0001800_abnormal_humoral_immune | 1.40501300 |
56 | MP0002452_abnormal_antigen_presenting | 1.40169545 |
57 | MP0005623_abnormal_meninges_morphology | 1.38888265 |
58 | MP0005166_decreased_susceptibility_to | 1.36348448 |
59 | MP0003075_altered_response_to | 1.35757061 |
60 | MP0000685_abnormal_immune_system | 1.31271703 |
61 | MP0010352_gastrointestinal_tract_polyps | 1.29114986 |
62 | MP0001849_ear_inflammation | 1.26733131 |
63 | MP0008004_abnormal_stomach_pH | 1.26695434 |
64 | MP0002723_abnormal_immune_serum | 1.26173455 |
65 | MP0001191_abnormal_skin_condition | 1.25742256 |
66 | * MP0009931_abnormal_skin_appearance | 1.24460212 |
67 | MP0005367_renal/urinary_system_phenotyp | 1.23814803 |
68 | MP0000516_abnormal_urinary_system | 1.23814803 |
69 | MP0001851_eye_inflammation | 1.23788654 |
70 | MP0003091_abnormal_cell_migration | 1.23360613 |
71 | MP0005508_abnormal_skeleton_morphology | 1.21738513 |
72 | MP0001879_abnormal_lymphatic_vessel | 1.20373124 |
73 | MP0002420_abnormal_adaptive_immunity | 1.19789364 |
74 | MP0003950_abnormal_plasma_membrane | 1.18833109 |
75 | MP0001819_abnormal_immune_cell | 1.18743743 |
76 | MP0009250_abnormal_appendicular_skeleto | 1.18645716 |
77 | MP0002282_abnormal_trachea_morphology | 1.17480381 |
78 | MP0005666_abnormal_adipose_tissue | 1.16747448 |
79 | MP0005023_abnormal_wound_healing | 1.13562844 |
80 | MP0001845_abnormal_inflammatory_respons | 1.12725296 |
81 | MP0000858_altered_metastatic_potential | 1.12051162 |
82 | MP0005397_hematopoietic_system_phenotyp | 1.11450007 |
83 | MP0001545_abnormal_hematopoietic_system | 1.11450007 |
84 | MP0004185_abnormal_adipocyte_glucose | 1.11063656 |
85 | MP0005670_abnormal_white_adipose | 1.09879340 |
86 | MP0002132_abnormal_respiratory_system | 1.06791688 |
87 | MP0000249_abnormal_blood_vessel | 1.06307015 |
88 | MP0002405_respiratory_system_inflammati | 1.05642001 |
89 | MP0005503_abnormal_tendon_morphology | 1.05504562 |
90 | MP0005076_abnormal_cell_differentiation | 1.03999867 |
91 | MP0009384_cardiac_valve_regurgitation | 1.03636854 |
92 | MP0001542_abnormal_bone_strength | 1.02244890 |
93 | MP0004782_abnormal_surfactant_physiolog | 1.02017884 |
94 | MP0005360_urolithiasis | 1.01858833 |
95 | MP0000537_abnormal_urethra_morphology | 1.00755765 |
96 | MP0003172_abnormal_lysosome_physiology | 0.99922778 |
97 | MP0006054_spinal_hemorrhage | 0.99118913 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.98006889 |
99 | MP0009333_abnormal_splenocyte_physiolog | 0.97731537 |
100 | MP0005165_increased_susceptibility_to | 0.97643055 |
101 | MP0002877_abnormal_melanocyte_morpholog | 0.97173510 |
102 | MP0003300_gastrointestinal_ulcer | 0.94529941 |
103 | MP0004264_abnormal_extraembryonic_tissu | 0.94468174 |
104 | MP0010368_abnormal_lymphatic_system | 0.93875171 |
105 | MP0003283_abnormal_digestive_organ | 0.93777146 |
106 | MP0000767_abnormal_smooth_muscle | 0.91936367 |
107 | MP0000613_abnormal_salivary_gland | 0.91002457 |
108 | MP0000343_altered_response_to | 0.90942192 |
109 | MP0004510_myositis | 0.89049709 |
110 | MP0008469_abnormal_protein_level | 0.88607659 |
111 | MP0003183_abnormal_peptide_metabolism | 0.88327699 |
112 | * MP0002166_altered_tumor_susceptibility | 0.88243563 |
113 | MP0002133_abnormal_respiratory_system | 0.87779969 |
114 | MP0005388_respiratory_system_phenotype | 0.87779969 |
115 | MP0001340_abnormal_eyelid_morphology | 0.87113451 |
116 | MP0010155_abnormal_intestine_physiology | 0.87092738 |
117 | MP0001986_abnormal_taste_sensitivity | 0.86542886 |
118 | MP0002896_abnormal_bone_mineralization | 0.86295723 |
119 | MP0003866_abnormal_defecation | 0.85458101 |
120 | MP0009764_decreased_sensitivity_to | 0.84966721 |
121 | MP0000049_abnormal_middle_ear | 0.84908967 |
122 | MP0005464_abnormal_platelet_physiology | 0.83497868 |
123 | MP0000427_abnormal_hair_cycle | 0.83036528 |
124 | MP0003755_abnormal_palate_morphology | 0.82721280 |
125 | MP0006138_congestive_heart_failure | 0.82265463 |
126 | MP0005390_skeleton_phenotype | 0.81527620 |
127 | MP0002933_joint_inflammation | 0.80817402 |
128 | MP0004883_abnormal_blood_vessel | 0.80483421 |
129 | MP0003763_abnormal_thymus_physiology | 0.80171200 |
130 | MP0002295_abnormal_pulmonary_circulatio | 0.77783453 |
131 | MP0005375_adipose_tissue_phenotype | 0.74627172 |
132 | MP0000716_abnormal_immune_system | 0.74328288 |
133 | MP0009115_abnormal_fat_cell | 0.74180953 |
134 | MP0002233_abnormal_nose_morphology | 0.73761215 |
135 | * MP0000367_abnormal_coat/_hair | 0.73701997 |
136 | MP0004808_abnormal_hematopoietic_stem | 0.73266121 |
137 | MP0002234_abnormal_pharynx_morphology | 0.71960428 |
138 | MP0003937_abnormal_limbs/digits/tail_de | 0.71809383 |
139 | MP0000678_abnormal_parathyroid_gland | 0.71549299 |
140 | MP0001873_stomach_inflammation | 0.71531783 |
141 | * MP0000470_abnormal_stomach_morphology | 0.70938259 |
142 | MP0000432_abnormal_head_morphology | 0.70898724 |
143 | MP0000163_abnormal_cartilage_morphology | 0.70489989 |
144 | MP0009278_abnormal_bone_marrow | 0.69597661 |
145 | MP0004484_altered_response_of | 0.68665100 |
146 | MP0005164_abnormal_response_to | 0.68071085 |
147 | MP0000465_gastrointestinal_hemorrhage | 0.67961403 |
148 | * MP0001784_abnormal_fluid_regulation | 0.64267572 |
149 | MP0003279_aneurysm | 0.63451116 |
150 | MP0005257_abnormal_intraocular_pressure | 0.63103536 |
151 | MP0001533_abnormal_skeleton_physiology | 0.61994544 |
152 | MP0002108_abnormal_muscle_morphology | 0.61906839 |
153 | MP0003191_abnormal_cellular_cholesterol | 0.61504621 |
154 | MP0003448_altered_tumor_morphology | 0.60734584 |
155 | MP0005409_darkened_coat_color | 0.60716582 |
156 | MP0000627_abnormal_mammary_gland | 0.60589253 |
157 | MP0003045_fibrosis | 0.59362539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 5.17191018 |
2 | Hypotrichosis (HP:0001006) | 4.97924587 |
3 | Parakeratosis (HP:0001036) | 4.81860672 |
4 | Eczematoid dermatitis (HP:0000976) | 4.64796380 |
5 | Fragile nails (HP:0001808) | 4.61530920 |
6 | Plantar hyperkeratosis (HP:0007556) | 4.39579118 |
7 | Woolly hair (HP:0002224) | 4.29055233 |
8 | Onycholysis (HP:0001806) | 4.24366400 |
9 | Amyloidosis (HP:0011034) | 4.07725569 |
10 | Distal lower limb muscle weakness (HP:0009053) | 4.06300516 |
11 | Milia (HP:0001056) | 4.06081473 |
12 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.97444394 |
13 | Atrophic scars (HP:0001075) | 3.80730586 |
14 | Increased IgE level (HP:0003212) | 3.73755147 |
15 | Abnormality of macrophages (HP:0004311) | 3.71618406 |
16 | Lip pit (HP:0100267) | 3.71127177 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.65262501 |
18 | Congenital, generalized hypertrichosis (HP:0004540) | 3.44450080 |
19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.38835890 |
20 | Recurrent abscess formation (HP:0002722) | 3.38759296 |
21 | Palmoplantar hyperkeratosis (HP:0000972) | 3.35972139 |
22 | Alopecia of scalp (HP:0002293) | 3.31959309 |
23 | Malnutrition (HP:0004395) | 3.31918972 |
24 | Palmar hyperkeratosis (HP:0010765) | 3.20459322 |
25 | Aplasia cutis congenita (HP:0001057) | 3.12133534 |
26 | Acanthosis nigricans (HP:0000956) | 3.12068454 |
27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04693952 |
28 | Abnormality of nail color (HP:0100643) | 3.03758284 |
29 | Myositis (HP:0100614) | 2.98348635 |
30 | Ectropion (HP:0000656) | 2.97737333 |
31 | Premature rupture of membranes (HP:0001788) | 2.92921268 |
32 | Systemic lupus erythematosus (HP:0002725) | 2.86144074 |
33 | Neonatal short-limb short stature (HP:0008921) | 2.83816738 |
34 | Esophageal atresia (HP:0002032) | 2.83775619 |
35 | Natal tooth (HP:0000695) | 2.81672476 |
36 | Nail dystrophy (HP:0008404) | 2.78217190 |
37 | Ventricular tachycardia (HP:0004756) | 2.75194254 |
38 | Stenosis of the external auditory canal (HP:0000402) | 2.72123819 |
39 | Abnormality of the axillary hair (HP:0100134) | 2.65749925 |
40 | Abnormality of secondary sexual hair (HP:0009888) | 2.65749925 |
41 | Upper limb muscle weakness (HP:0003484) | 2.62012316 |
42 | Orchitis (HP:0100796) | 2.60049861 |
43 | Thick nail (HP:0001805) | 2.58632115 |
44 | Advanced eruption of teeth (HP:0006288) | 2.56927300 |
45 | Interstitial pulmonary disease (HP:0006530) | 2.56063949 |
46 | Sparse eyelashes (HP:0000653) | 2.55573529 |
47 | Follicular hyperkeratosis (HP:0007502) | 2.51112346 |
48 | Hyperactive renin-angiotensin system (HP:0000841) | 2.50305331 |
49 | Spondylolisthesis (HP:0003302) | 2.50114365 |
50 | Abnormal blistering of the skin (HP:0008066) | 2.49465940 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49307835 |
52 | Abnormality of the 2nd finger (HP:0004100) | 2.48471111 |
53 | Fragile skin (HP:0001030) | 2.48224599 |
54 | Ulnar claw (HP:0001178) | 2.46729860 |
55 | Erythroderma (HP:0001019) | 2.43311709 |
56 | Dysostosis multiplex (HP:0000943) | 2.42670253 |
57 | Recurrent skin infections (HP:0001581) | 2.42365409 |
58 | Hypohidrosis (HP:0000966) | 2.42093068 |
59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41197136 |
60 | Osteolytic defects of the hand bones (HP:0009699) | 2.41197136 |
61 | Gingivitis (HP:0000230) | 2.40591197 |
62 | Down-sloping shoulders (HP:0200021) | 2.39176672 |
63 | Erythema (HP:0010783) | 2.37228680 |
64 | Pterygium (HP:0001059) | 2.36825460 |
65 | Short hallux (HP:0010109) | 2.35392532 |
66 | Sparse scalp hair (HP:0002209) | 2.33474353 |
67 | Pili torti (HP:0003777) | 2.32428859 |
68 | Corneal erosion (HP:0200020) | 2.31307884 |
69 | Retrobulbar optic neuritis (HP:0100654) | 2.28742103 |
70 | Optic neuritis (HP:0100653) | 2.28742103 |
71 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.25289235 |
72 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.25085336 |
73 | Curly hair (HP:0002212) | 2.24750967 |
74 | Popliteal pterygium (HP:0009756) | 2.22835582 |
75 | Keratoconjunctivitis sicca (HP:0001097) | 2.21961538 |
76 | Urticaria (HP:0001025) | 2.20860189 |
77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18012156 |
78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18012156 |
79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18012156 |
80 | Stomatitis (HP:0010280) | 2.17270760 |
81 | Oligodontia (HP:0000677) | 2.16877589 |
82 | Aortic aneurysm (HP:0004942) | 2.16558416 |
83 | Axonal loss (HP:0003447) | 2.15817724 |
84 | Abnormal vertebral ossification (HP:0100569) | 2.14222508 |
85 | Polygenic inheritance (HP:0010982) | 2.14100074 |
86 | Hypoplasia of dental enamel (HP:0006297) | 2.13637168 |
87 | Increased cerebral lipofuscin (HP:0011813) | 2.13407816 |
88 | Myocardial infarction (HP:0001658) | 2.13377669 |
89 | Prostate neoplasm (HP:0100787) | 2.13164320 |
90 | Colitis (HP:0002583) | 2.12603124 |
91 | Increased connective tissue (HP:0009025) | 2.11662212 |
92 | Pruritus (HP:0000989) | 2.10358836 |
93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.10286816 |
94 | Thin bony cortex (HP:0002753) | 2.10234548 |
95 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.08963968 |
96 | Hematochezia (HP:0002573) | 2.08856710 |
97 | Concave nail (HP:0001598) | 2.08798615 |
98 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.08067065 |
99 | Broad face (HP:0000283) | 2.08003464 |
100 | Abnormality of complement system (HP:0005339) | 2.06366990 |
101 | Stomach cancer (HP:0012126) | 2.05314366 |
102 | Hyporeflexia of lower limbs (HP:0002600) | 2.05235306 |
103 | Hemoptysis (HP:0002105) | 2.03304781 |
104 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.02448565 |
105 | Hip contracture (HP:0003273) | 2.00272591 |
106 | Spontaneous hematomas (HP:0007420) | 1.99971755 |
107 | Distal lower limb amyotrophy (HP:0008944) | 1.99705596 |
108 | Xerostomia (HP:0000217) | 1.96859826 |
109 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96376404 |
110 | Mucopolysacchariduria (HP:0008155) | 1.96376404 |
111 | Polycythemia (HP:0001901) | 1.95504212 |
112 | Keratoconjunctivitis (HP:0001096) | 1.94225089 |
113 | Hypertriglyceridemia (HP:0002155) | 1.94140616 |
114 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.93933805 |
115 | Vertebral hypoplasia (HP:0008417) | 1.93933805 |
116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93922399 |
117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93922399 |
118 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93922399 |
119 | Corneal dystrophy (HP:0001131) | 1.93456078 |
120 | Hypergammaglobulinemia (HP:0010702) | 1.93197635 |
121 | Spinal rigidity (HP:0003306) | 1.93151216 |
122 | Dilatation of the ascending aorta (HP:0005111) | 1.91940593 |
123 | Conical tooth (HP:0000698) | 1.91409848 |
124 | Vertebral clefting (HP:0008428) | 1.90707819 |
125 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.90486989 |
126 | Anhidrosis (HP:0000970) | 1.90221096 |
127 | Gangrene (HP:0100758) | 1.89955779 |
128 | Abnormal hemoglobin (HP:0011902) | 1.89587495 |
129 | Blepharitis (HP:0000498) | 1.89444037 |
130 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.89203279 |
131 | Cellulitis (HP:0100658) | 1.88930525 |
132 | Increased serum ferritin (HP:0003281) | 1.87325355 |
133 | Mediastinal lymphadenopathy (HP:0100721) | 1.87302680 |
134 | Vacuolated lymphocytes (HP:0001922) | 1.86941311 |
135 | Cervical subluxation (HP:0003308) | 1.86825060 |
136 | Gastrointestinal infarctions (HP:0005244) | 1.86525049 |
137 | Inflammation of the large intestine (HP:0002037) | 1.86174985 |
138 | Cerebral aneurysm (HP:0004944) | 1.85938092 |
139 | Asymmetric septal hypertrophy (HP:0001670) | 1.85299168 |
140 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85131430 |
141 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85131430 |
142 | Aplasia involving bones of the extremities (HP:0009825) | 1.85131430 |
143 | Episodic fever (HP:0001954) | 1.85013903 |
144 | Recurrent fungal infections (HP:0002841) | 1.84961952 |
145 | Hypodontia (HP:0000668) | 1.84870457 |
146 | Protrusio acetabuli (HP:0003179) | 1.84680752 |
147 | Decreased circulating renin level (HP:0003351) | 1.84350660 |
148 | Pulmonary infiltrates (HP:0002113) | 1.81587868 |
149 | Pustule (HP:0200039) | 1.81396974 |
150 | Vasculitis (HP:0002633) | 1.79875382 |
151 | Loss of speech (HP:0002371) | 1.78894950 |
152 | Prolonged bleeding time (HP:0003010) | 1.78756197 |
153 | Premature loss of primary teeth (HP:0006323) | 1.78282618 |
154 | Cheilitis (HP:0100825) | 1.77875332 |
155 | Abnormal number of erythroid precursors (HP:0012131) | 1.77582296 |
156 | Gastrointestinal inflammation (HP:0004386) | 1.77152078 |
157 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.75447140 |
158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.75447140 |
159 | Congenital malformation of the right heart (HP:0011723) | 1.75056445 |
160 | Double outlet right ventricle (HP:0001719) | 1.75056445 |
161 | Skin ulcer (HP:0200042) | 1.74640557 |
162 | Abnormality of the salivary glands (HP:0010286) | 1.74558793 |
163 | Abnormality of the gastric mucosa (HP:0004295) | 1.72899605 |
164 | Bone cyst (HP:0012062) | 1.72624362 |
165 | Flat acetabular roof (HP:0003180) | 1.70475358 |
166 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.69833008 |
167 | Hypoplastic labia majora (HP:0000059) | 1.69725438 |
168 | Ridged nail (HP:0001807) | 1.68535071 |
169 | Skin pits (HP:0100276) | 1.67954440 |
170 | Absent eyebrow (HP:0002223) | 1.67481643 |
171 | Limited hip movement (HP:0008800) | 1.67260773 |
172 | Gastrointestinal atresia (HP:0002589) | 1.66729328 |
173 | Absent toe (HP:0010760) | 1.66219313 |
174 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.65619563 |
175 | Single umbilical artery (HP:0001195) | 1.65619563 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST4 | 4.95214966 |
2 | MST1R | 3.98462298 |
3 | MAPK15 | 3.55518516 |
4 | MAP2K2 | 3.45045023 |
5 | PRPF4B | 3.24083705 |
6 | EPHB2 | 2.87512553 |
7 | PIM2 | 2.86215263 |
8 | RIPK4 | 2.83984770 |
9 | BLK | 2.69002172 |
10 | TIE1 | 2.60610909 |
11 | NUAK1 | 2.46273723 |
12 | RIPK1 | 2.45460669 |
13 | EPHA2 | 2.36792524 |
14 | MAPKAPK3 | 2.35038705 |
15 | MAP3K3 | 2.30639514 |
16 | FER | 2.22735806 |
17 | ERN1 | 2.21682662 |
18 | DMPK | 2.13107745 |
19 | RPS6KB2 | 1.97108467 |
20 | PIK3CA | 1.87908606 |
21 | MAP2K3 | 1.83086748 |
22 | TGFBR2 | 1.80729896 |
23 | MET | 1.79388566 |
24 | MAP3K6 | 1.68958220 |
25 | ZAP70 | 1.64237973 |
26 | MAP3K13 | 1.62300176 |
27 | IRAK4 | 1.62166619 |
28 | GRK1 | 1.57550118 |
29 | MAP3K14 | 1.56652216 |
30 | TRPM7 | 1.56308902 |
31 | EPHB1 | 1.44498165 |
32 | MOS | 1.40860717 |
33 | STK10 | 1.39520404 |
34 | MAP3K2 | 1.37024155 |
35 | PDK2 | 1.36049782 |
36 | TRIB3 | 1.35573853 |
37 | KIT | 1.34156162 |
38 | MAPKAPK5 | 1.32649097 |
39 | STK38L | 1.31759414 |
40 | IRAK1 | 1.28674409 |
41 | FES | 1.26317202 |
42 | DDR2 | 1.25462233 |
43 | IKBKB | 1.19509241 |
44 | SIK1 | 1.16920613 |
45 | MAP3K7 | 1.16314849 |
46 | PIM1 | 1.14934018 |
47 | LATS1 | 1.14748330 |
48 | GRK6 | 1.14587547 |
49 | TEC | 1.12810490 |
50 | IRAK2 | 1.11492058 |
51 | MAPK12 | 1.09345400 |
52 | KDR | 1.05977323 |
53 | PDPK1 | 1.04890335 |
54 | EPHA3 | 1.03430338 |
55 | PTK6 | 1.03215950 |
56 | MAP2K1 | 1.02747250 |
57 | JAK3 | 1.00915443 |
58 | JAK1 | 0.99930460 |
59 | BCR | 0.99324754 |
60 | CDK6 | 0.97579333 |
61 | IRAK3 | 0.97534805 |
62 | AKT3 | 0.96981105 |
63 | MAP4K1 | 0.96617429 |
64 | STK24 | 0.96553960 |
65 | CDC42BPA | 0.95981426 |
66 | CSF1R | 0.95663067 |
67 | TTN | 0.93857303 |
68 | NEK6 | 0.86179259 |
69 | CDK3 | 0.85724489 |
70 | ABL2 | 0.85586189 |
71 | PAK2 | 0.84446014 |
72 | RPS6KA2 | 0.84141209 |
73 | GSK3A | 0.83119847 |
74 | TAOK2 | 0.82885192 |
75 | MARK2 | 0.82656408 |
76 | PIK3CG | 0.80783029 |
77 | LRRK2 | 0.80561035 |
78 | MAPK7 | 0.79870173 |
79 | DYRK1B | 0.79009877 |
80 | HCK | 0.78644921 |
81 | LMTK2 | 0.78549782 |
82 | PRKG2 | 0.78188941 |
83 | MAPKAPK2 | 0.77702832 |
84 | RPS6KL1 | 0.77295603 |
85 | RPS6KC1 | 0.77295603 |
86 | FGFR2 | 0.74984735 |
87 | PDK1 | 0.73086349 |
88 | CHUK | 0.72726851 |
89 | STK3 | 0.71632812 |
90 | BTK | 0.69364408 |
91 | CSK | 0.69088490 |
92 | JAK2 | 0.68292854 |
93 | EEF2K | 0.68116282 |
94 | IKBKE | 0.66987054 |
95 | ACVR1B | 0.66322057 |
96 | BMX | 0.65928757 |
97 | TAOK1 | 0.65029377 |
98 | MTOR | 0.64740103 |
99 | KSR2 | 0.64717579 |
100 | NLK | 0.63063653 |
101 | RPS6KA6 | 0.61223608 |
102 | PRKD1 | 0.60432320 |
103 | ITK | 0.59931904 |
104 | TYK2 | 0.56461695 |
105 | MATK | 0.54825421 |
106 | RAF1 | 0.54507742 |
107 | TNK2 | 0.54145064 |
108 | SYK | 0.53901344 |
109 | PRKD2 | 0.53659964 |
110 | PRKCI | 0.52650616 |
111 | PRKCE | 0.52279971 |
112 | FRK | 0.51691776 |
113 | GRK7 | 0.50019050 |
114 | INSRR | 0.49524485 |
115 | ICK | 0.49191623 |
116 | YES1 | 0.48827237 |
117 | TBK1 | 0.48119662 |
118 | PDGFRB | 0.47830228 |
119 | BMPR1B | 0.46640437 |
120 | ILK | 0.46430344 |
121 | PAK4 | 0.46039383 |
122 | PKN1 | 0.45506780 |
123 | TGFBR1 | 0.43659900 |
124 | LYN | 0.42885438 |
125 | CDK12 | 0.41837783 |
126 | ERBB4 | 0.41694238 |
127 | PBK | 0.41392660 |
128 | ROCK1 | 0.41351273 |
129 | ROCK2 | 0.40940083 |
130 | FGFR4 | 0.40033781 |
131 | MAPK3 | 0.39288833 |
132 | MYLK | 0.38508907 |
133 | MAP3K1 | 0.36854346 |
134 | ZAK | 0.36413697 |
135 | FGR | 0.36054658 |
136 | PRKAA2 | 0.35425546 |
137 | RPS6KA1 | 0.33839100 |
138 | FGFR3 | 0.33415558 |
139 | MAPK1 | 0.33297462 |
140 | ABL1 | 0.31794637 |
141 | HIPK2 | 0.30202595 |
142 | VRK1 | 0.29902136 |
143 | BMPR2 | 0.29514233 |
144 | MAPK4 | 0.29053520 |
145 | PTK2 | 0.27931441 |
146 | INSR | 0.27207509 |
147 | STK39 | 0.27112463 |
148 | LATS2 | 0.26980868 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Adherens junction_Homo sapiens_hsa04520 | 2.56889880 |
2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.54933257 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48072523 |
4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.42505750 |
5 | Ribosome_Homo sapiens_hsa03010 | 2.35170293 |
6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.21440029 |
7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.18252065 |
8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.13969354 |
9 | Mineral absorption_Homo sapiens_hsa04978 | 2.01748644 |
10 | Tight junction_Homo sapiens_hsa04530 | 1.96748974 |
11 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.73267841 |
12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68511163 |
13 | Asthma_Homo sapiens_hsa05310 | 1.66719304 |
14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65036048 |
15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.64441648 |
16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61305369 |
17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.60329833 |
18 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.60244601 |
19 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.58883069 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.57249223 |
21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.57206549 |
22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.56306475 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.55096406 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.46274128 |
25 | Allograft rejection_Homo sapiens_hsa05330 | 1.42532905 |
26 | Amoebiasis_Homo sapiens_hsa05146 | 1.40849999 |
27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39067007 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.35953316 |
29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34627667 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33789631 |
31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31984752 |
32 | Focal adhesion_Homo sapiens_hsa04510 | 1.31187130 |
33 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.30843932 |
34 | Bladder cancer_Homo sapiens_hsa05219 | 1.29090968 |
35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27827034 |
36 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25780384 |
37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24608311 |
38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21208275 |
39 | Malaria_Homo sapiens_hsa05144 | 1.20799826 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20569997 |
41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19683918 |
42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18976191 |
43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.18686412 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15751482 |
45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12316117 |
46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11731673 |
47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.11662395 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09734922 |
49 | Lysosome_Homo sapiens_hsa04142 | 1.09407110 |
50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08079457 |
51 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05429179 |
52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03352733 |
53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02470761 |
54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01677540 |
55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00109578 |
56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99804402 |
57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99271561 |
58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98320389 |
59 | Pathways in cancer_Homo sapiens_hsa05200 | 0.97785123 |
60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96174367 |
61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91690573 |
62 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.91404065 |
63 | Salmonella infection_Homo sapiens_hsa05132 | 0.91193246 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90922894 |
65 | Axon guidance_Homo sapiens_hsa04360 | 0.89763557 |
66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88947512 |
67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87750584 |
68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87366403 |
69 | Prostate cancer_Homo sapiens_hsa05215 | 0.85873986 |
70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85499832 |
71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84994026 |
72 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.84916323 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84661697 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.84429572 |
75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83774964 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 0.82735990 |
77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82388069 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.81968373 |
79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81833504 |
80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81816098 |
81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81291859 |
82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81260753 |
83 | Pertussis_Homo sapiens_hsa05133 | 0.81071420 |
84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.80287942 |
85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80077903 |
86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79845913 |
87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79549288 |
88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78796850 |
89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78165099 |
90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78022279 |
91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77858330 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77855163 |
93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77852487 |
94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73033744 |
95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72588446 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72376557 |
97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71120058 |
98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70183736 |
99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69978109 |
100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69802879 |
101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69499716 |
102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69186903 |
103 | Hepatitis C_Homo sapiens_hsa05160 | 0.68659877 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67504604 |
105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67345166 |
106 | Shigellosis_Homo sapiens_hsa05131 | 0.67176855 |
107 | Platelet activation_Homo sapiens_hsa04611 | 0.66994014 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65429158 |
109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64949849 |
110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64786853 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64575308 |
112 | Melanogenesis_Homo sapiens_hsa04916 | 0.64187409 |
113 | Measles_Homo sapiens_hsa05162 | 0.64064600 |
114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63616198 |
115 | ABC transporters_Homo sapiens_hsa02010 | 0.61790675 |
116 | Apoptosis_Homo sapiens_hsa04210 | 0.61627046 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60470286 |
118 | Melanoma_Homo sapiens_hsa05218 | 0.60423497 |
119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59560507 |
120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58891030 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58670442 |
122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58547368 |
123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58393351 |
124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57942215 |
125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56918962 |
126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56632761 |
127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55997789 |
128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55534192 |
129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55435147 |
130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55160748 |
131 | Endocytosis_Homo sapiens_hsa04144 | 0.55020151 |
132 | Renin secretion_Homo sapiens_hsa04924 | 0.54438239 |
133 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53433121 |
134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52934079 |
135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51300992 |
136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50781702 |
137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50346200 |
138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49431810 |
139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48778915 |
140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46967847 |
141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43999714 |
142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43307280 |
143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42890756 |
144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42586368 |
145 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41976427 |